Skip to content
Neurology Minute cover art

All episodes

Neurology Minute, 1,000 episodes. Page 5 of 10.

#
Title
401

Neuroimmunology Update 2025: AQP4+ NMOSD Treatment Landscape

402

BTK Inhibitors in Multiple Sclerosis Treatment - Part 3

403

BTK Inhibitors in Multiple Sclerosis Treatment - Part 2

404

BTK Inhibitors in Multiple Sclerosis Treatment - Part 1

405

Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis

406

Women History Minute - Mary A. B. Brazier

407

The Landscape of Adult Neurology Residency Didactic Curricula in the United States - Part 2

408

The Landscape of Adult Neurology Residency Didactic Curricula in the United States - Part 1

409

Characterizing Prodrome in Migraine

410

Estrogen Exposure from Modern Hormonal Contraceptives and Vascular Risk in Women with Migraine: A Nationwide Electronic Health Record Database Study

411

The Latest Data from Lenadogene Nolparvovec Gene Therapy Trials for Leber Hereditary Optic Neuropathy - Part 4

412

Reducing Health Care Costs with Functional Seizures Clinic Referral

413

Neurology® Open Access - Part 2

414

Neurology® Open Access - Part 1

415

The Latest Data from Lenadogene Nolparvovec Gene Therapy Trials for Leber Hereditary Optic Neuropathy - Part 3

416

The Latest Data from Lenadogene Nolparvovec Gene Therapy Trials for Leber Hereditary Optic Neuropathy -Part 2

417

A Discussion with Dr. Gebreyohanns: 2025 Ted Burns Humanism in Neurology Award - Part 2

418

A Discussion with Dr. Gebreyohanns: 2025 Ted Burns Humanism in Neurology Award - Part 1

419

Trends and Disparities in the Utilization of Thymectomy for MG in the US

420

The Latest Data from Lenadogene Nolparvovec Gene Therapy Trials for Leber Hereditary Optic Neuropathy -Part 1

421

Busting Myths in Sleep, Headache and Concussion

422

Cytokine, Chemokine, and Neurofilament Light Chain Signatures in Anti-LGI-1 Encephalitis - Part 4

423

Ten Years of Neurology® Genetics

424

Global Recommendations for Migraine

425

Cytokine, Chemokine, and Neurofilament Light Chain Signatures in Anti-LGI-1 Encephalitis - Part 3

426

Cytokine, Chemokine, and Neurofilament Light Chain Signatures in Anti-LGI-1 Encephalitis - Part 2

427

Cytokine, Chemokine, and Neurofilament Light Chain Signatures in Anti-LGI-1 Encephalitis - Part 1

428

Association of Smoking and Young Cryptogenic Ischemic Stroke

429

Revolutionizing ALS Treatment: The Tofersen Breakthrough

430

Neurology on the Hill 2025 - Part 3

431

Neurology on the Hill 2025 - Part 2

432

Neurology on the Hill 2025 - Part 1

433

Frontotemporal Dementia Differential Diagnosis in Clinical Practice

434

The Best of Headache Medicine from 2024: A Year in Review

435

The Best of Headache Medicine from 2024: A Year in Review

436

Sleep and Brain Health

437

Sleep Apnea and Stroke Risk

438

Association of Migraine Treatments with Reduced Ischemic Stroke Risk

439

Investigating Whether Dissemination in Time Is Essential to Diagnose Relapsing MS

440

Overview from the 2025 International Stroke Conference - Part 2

441

Overview from the 2025 International Stroke Conference - Part 1

442

Acquired Dystonia

443

Orthostatic Tremor

444

Exploring GLP-1 Receptor Agonists for Neurodegeneration - Part 2

445

Exploring GLP-1 Receptor Agonists for Neurodegeneration - Part 1

446

Vascular Risk Factor Burden Among Young Adults with Ischemic Stroke

447

First Drug Approved in New Class of Non-Opioid Pain Medicines

448

Lab Minute - Antiphospholipid Syndrome

449

Epidural Steroids for Cervical and Lumbar Radicular Pain and Spinal Stenosis

450

The Neurologist's Role in Promoting Brain Health

451

Association of Race and Ethnicity With Emergency Room Rate of Migraine Diagnosis, Testing, and Management in Children With Headache

452

Consensus Recommendations for the Management of Neurosarcoidosis - Part 2

453

Women History Minute - Audrey Shields Penn

454

Consensus Recommendations for the Management of Neurosarcoidosis - Part 1

455

Effects of Intensive Lifestyle Changes on the Progression of MCI or Early Dementia

456

Women History Minute - Anne Beaumanoir

457

New Restless Leg Syndrome Guidance - Part 2

458

Burnout in Practicing Neurologists - Part 4

459

New Restless Leg Syndrome Guidance - Part 1

460

Dementia Prevention, Intervention, and Care

461

Burnout in Practicing Neurologists - Part 3

462

Burnout in Practicing Neurologists - Part 2

463

Burnout in Practicing Neurologists - Part 1

464

The Brain's Action-Mode Network

465

Ten Years of Neurology® Neuroimmunology & Neuroinflammation Decade in Review - Part 2

466

Ten Years of Neurology® Neuroimmunology & Neuroinflammation Decade in Review - Part 1

467

Autoimmune Epilepsy

468

Kinetic Oscillation Stimulation for the Preventive Treatment of Chronic Migraine

469

Superhuman Performance of a LLM on the Reasoning Tasks of a Physician

470

Attitudes and Perceptions on Palliative Care

471

Enhancing Adherence to PAP Therapy

472

Understanding Circadian Rhythm

473

Women History Minute - Mary Whiton Calkins

474

CSF Correction Factors for Traumatic Lumbar Puncture in Adults

475

Changes in Cerebral and Hypothalamic Structure With Sleep Dysfunction in Patients With Genetic FTD

476

Women History Minute - Maria Mikhaĭlovna Manàsseina

477

Women History Minute - Ana Judith Roman Garcia

478

Paraneoplastic Neurologic Syndromes Associated With Merkel Cell Carcinoma - Part 2

479

Paraneoplastic Neurologic Syndromes Associated With Merkel Cell Carcinoma - Part 1

480

Using Design Thinking to Understand the Reason for Headache Referrals

481

Lab Minutes - Paraneoplastic Lab

482

Lab Minutes - Myasthenia Gravis Lab

483

Lab Minutes - IgG vs. IgM

484

Clinical Implementation of fMRI and EEG to Detect CMD

485

2024 Guideline for the Primary Prevention of Stroke - Part 5

486

2024 Guideline for the Primary Prevention of Stroke - Part 4

487

Empowering Health Care Providers

488

2024 Guideline for the Primary Prevention of Stroke - Part 3

489

Disparities in Utilization of Outpatient Telemedicine for Neurologic Care

490

2024 Guideline for the Primary Prevention of Stroke - Part 2

491

2024 Guideline for the Primary Prevention of Stroke - Part 1

492

Artificial Intelligence in Residency Recruitment - Part 2

493

IGLON5 Frequency in Idiopathic REM Sleep Behavior Disorder - Part 2

494

IGLON5 Frequency in Idiopathic REM Sleep Behavior Disorder - Part 1

495

Artificial Intelligence in Residency Recruitment - Part 1

496

EEG Education in Child Neurology and Neurodevelopmental Disabilities Residencies - Part 3

497

EEG Education in Child Neurology and Neurodevelopmental Disabilities Residencies - Part 2

498

EEG Education in Child Neurology and Neurodevelopmental Disabilities Residencies - Part 1

499

Central Mechanisms of Cough and Their Neurologic Implications

500

Medical Forecasting - Part 2